• ) is synthesized in skeletal muscle and its production increases during contractile activity. Although myosin is the most abundant protein in muscle, it is not known whether myosin is a target of NO
INTRODUCTION
Myosin (M r ∼ = 500 000) is the most abundant protein in skeletal muscle, where it accounts for nearly 60 % of the total myofibrillar proteins. It has a large impact on the demand for ATP during muscle contraction due to its ability to convert chemical energy derived from ATP hydrolysis into mechanical work. Myosin's 42 cysteine residues, most of which are reduced in the native protein [1] , are distributed among two heavy chains and four light chains. In adult skeletal muscle, the low turnover rate of myosin (halflife ∼ 30 days [2] ) makes it a potential target for functionally significant post-translational modifications, including protein S-nitrosylation, the reaction of protein cysteine thiols with nitrosonium ion (NO + ) equivalents to form protein-SNOs (protein
S-nitrosothiols).
Skeletal muscle is capable of producing NO • (for a review, see [3] ), and the NO
• formed during contractile activity is not significantly metabolized by myoglobin [4] . Several authors have postulated that either NO
• or low-molecular-mass SNOs (S-nitrosothiols) inhibit muscle force production and may lead to S-nitrosylation of contractile proteins [5] [6] [7] [8] . In fact, among sarcomeric contractile and regulatory proteins, only actin has been examined for functional changes caused by SNO formation [9] . Oxidizing or alkylating agents such as peroxynitrite and NEM (Nethylmaleimide) can alter myosin ATPase activity and its affinity for actin in vitro [10, 11] . However, it is not known whether myosin is capable of redox-based regulation by NO
• or low-mass SNOs.
The formation of RSNOs, including protein-SNO, in biological systems may occur by a number of different mechanisms, including the direct reaction of protein thiol with NO
• or its auto-oxidation products or transnitrosylative transfer of NO + from protein-bound or low-mass SNO to protein thiol [12] . The importance of transnitrosylation is evident by an increase in constitutive SNOs in cells and tissues devoid of the GSNO (S-nitrosoglutathione)-metabolizing enzyme, GSNO reductase. GSNO, the naturally occurring S-nitrosylated derivative of glutathione, is also widely used as a nitroso donor in cells. In skeletal muscle, the concentration of GSNO is unknown; however, glutathione is the most abundant low-molecular-mass thiol, between 1 and 3 mM [13] .
In the present study, we have shown for the first time that skeletal muscle promotes formation of protein-SNO in vivo after acute exercise. We show too that myosin is a site for SNO formation in cultured myotubes, and, in myofibrils, both myosin and actin are targets. S-nitrosylation promotes a significant reduction in the Mg 2+ -ATPase activity of myosin and actomyosin, but does not change the actin-myosin affinity. When DEANO (diethylamine NONOate) is used as an NO
• donor, neither myosin-SNO formation nor Mg 2+ -ATPase inhibition occurs, suggesting that transnitrosylation is the main pathway for myosin-SNO formation. The inhibition of Mg 2+ -ATPase activity accompanies the formation of around four unstable SNO groups in myosin, suggesting the possibility that a transient S-nitrosylation in vivo might contribute to the regulation of actomyosin during exercise or nitrosative stress.
EXPERIMENTAL Materials
Glutathione, cysteine, NEM, Sephadex G-25, HgCl 2 , DTNB [5,5 -dithiobis-(2-nitrobenzoic acid)], ATP (Grade I), EDTA, EGTA, imidazole, Hepes, Tris, DTT (dithiothreitol), MgCl 2 , CaCl 2 and BSA were purchased from Sigma-Aldrich. GdmCl (guanidinium chloride) was from Acros Organics, urea was from Merck, MMTS (methylmethanethiosulfonate) was from Calbiochem, biotin-HPDP {N- [6-(biotinamido) hexyl]-3 -(2 -pyridyldithio)-propionamide} was from Pierce, DEANO sodium salt was from Molecular Probes and thiopropyl-Sepharose 6B was from GE Healthcare. Other salts were from Brazilian suppliers. Mouse monoclonal antibody IgG1 against MHC (myosin heavy chain) (MA1-16774) was purchased from Affinity Bioreagents and anti-mouse secondary antibody IgG was from Promega.
Synthesis of SNOs
GSNO and CysNO (S-nitrosocysteine) were freshly prepared before each experiment by mixing glutathione or cysteine (acidified in 0.1 M HCl) with equimolar concentrations of NaNO 2 [9] . After 1-2 min, the reaction was stopped by addition of 50 mM imidazole containing 0.1 mM EDTA and titrated with KOH to pH 7.0. The concentration was determined by measuring absorbance at 335 nm (ε 335 = 900 M −1 · cm −1 for both GSNO and CysNO).
Purification of myosin, actin and skinned muscle fibres
Skeletal muscle myosin was obtained from rabbit back muscles as described previously [14] and stored at −20 • C in 50% (v/v) glycerol at high ionic strength (0.6 M KCl and 50 mM imidazole, pH 7). Before use, the glycerol was removed, and the protein concentration was determined using the Biuret method, using BSA as a standard.
Chicken skeletal muscle actin was purified [15] and polymerized [16] essentially as described previously, but in the absence of DTT. There was no difference in actin-activated myosin ATPase activity in the presence or absence of DTT (results not shown).
Skinned skeletal muscle fibres were prepared from rabbit psoas muscle and stored at −20
• C in 50% (v/v) glycerol containing relaxing solution (152 mM potassium propionate, 20 mM imidazole propionate, pH 7.0, 6.4 mM magnesium acetate, 5 mM EGTA and 4.4 mM ATP) and a cocktail of protease inhibitors [17] . Glycerol was removed before use.
Cell culture
Mouse-derived C2C12 myoblasts were maintained in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % (v/v) FBS (fetal bovine serum), 100 units/ml penicillin G and 100 μg/ml streptomycin and incubated at 37
• C in ambient air with 5 % CO 2 . To differentiate the cells to myotubes, DMEM with 10 % FBS was replaced by DMEM with 2 % (v/v) horse serum, and cells were allowed to differentiate for 10 days, changing the medium every 2 days [18] .
Total protein-SNO in vivo and in myofibrils
Male Sprague-Dawley rats (300-350 g body weight) were exercised intensely by swimming against a load (15 % of the total body weight, attached to the tail) for 4.7 min (14 cycles of 20 s with 10 s rest). Non-exercised rats were handled and placed in the tank, but had no load and were not forced to swim. After exercise, animals were killed using sodium pentobarbital (30 mg/kg of body weight) and the EDL (extensor digitorum longus) muscles from both hindlimbs were removed, weighed wet and homogenized for 15 s in the dark at 0
• C using a Polytron PTA10 probe and 2 ml of buffer/250 mg of wet weight (1-2 % Triton X-100, 20 mM Tris/HCl, pH 7.7, 0.1 mM neocuproine, 1 mM EGTA, 1 mM EDTA, 1 mM NaVO 4 , 2.5 mM sodium pyrophosphate and 1 mM PMSF), followed by centrifugation at 500 g for 10 min. In some experiments, sodium pyrophosphate/NaVO 4 was replaced with Mg-ATP and 0.6 M KCl [19] . The supernatant was used to measure NO 2 − and protein-SNO by Saville's method (as described below for myosin-SNO) [20] and total protein using the Biuret method. The experiments were approved by the Committee for Ethics in Animal Experimentation of the Federal University of Rio de Janeiro (Protocol # IBQM 024/031), Brazil.
Differentiated myotubes (in 100-mm-diameter×20-mm-high dishes) were treated with 500 μM CysNO for 0-60 min at 37
• C in differentiation medium. The medium was removed, and cells were washed twice with 2 ml of PBS supplemented with 0.1 mM EDTA (PBS-EDTA), followed by lysis and the SNO-RAC (protein-SNO detection by resin-assisted capture) assay described below.
Small bundles of skinned muscle fibres (50 mg of wet weight) were treated with 0.5 ml of GSNO (0.01-1 mM) for 30 min at 30
• C in relaxing solution. Unreacted GSNO was removed by washing three times with 0.5 ml of relaxing solution, and proteins were solubilized in 1 ml of buffer A (25 mM Hepes, pH 7.7, 4 mM EGTA, 4 mM MgCl 2 , 2 mM ATP and 0.1 mM neocuproine) containing 0.3 M KCl. The biotin-switch assay was carried out as described below.
Quantification of myosin-SNO
Myosin S-nitrosylation was carried out using fresh GSNO at 30
• C in the ionic condition that promotes the classical Mg 2+ -ATPase activity of myosin [21] , but without ATP. This Mg 2+ buffer contained 50 mM imidazole, pH 7, 50 mM KCl, 0.2 mM EDTA and 5 mM MgCl 2 . To start the reaction, GSNO (final concentration 1 μM-8 mM) was added to the Mg 2+ buffer containing 4 mg of purified myosin in a final volume of 2 ml. After 15-120 min, 5 ml of cold water was added, followed by centrifugation at 2700 g for 15 min, and the pellet (0.1 ml) was solubilized in 1 ml of high-ionic-strength buffer (0.6 M KCl and 50 mM imidazole, pH 7; one wash). The washing was repeated again (two washes) or up to five times to remove unreacted GSNO. After two to five washes, the solubilized pellet was covered with foil to diminish SNO decomposition by light [22] . Myosin-SNO was determined colorimetrically on 40 μl (∼ 40 μg) of myosin in a final volume of 0.5 ml. NO 2 − was measured using the Griess reagent with and without 3 mM HgCl 2 , to decompose SNO [20] , followed by centrifugation at 2000 g for 10 min to avoid light scattering from precipitated protein. The difference between the absorbance of the supernatant with and without HgCl 2 addition was taken to represent the amount of protein-SNO. Standard curves were constructed using NaNO 2 , and protein concentration was determined using the method of Lowry et al. [23] .
Detection of protein-SNO by the biotin-switch assay and by the SNO-RAC method Detection of protein-SNO was carried out in myofibrillar proteins from rat EDL muscle (as described above), C2C12 myotubes (2 mg of protein), skinned skeletal muscle fibres (50 mg of wet weight) and in purified myosin (2 mg/ml) using the methods described in [22, 24] with some modifications. When an exogenous RSNO donor was used, the excess was removed after the S-nitrosylation step by washing with PBS-EDTA (for myotubes) or with relaxing buffer (for skinned muscle fibres) or with buffer B (20-100 mM Tris/HCl, pH 7.7, 1 mM EDTA and 0.1 mM neocuproine) followed by centrifugation at 2000 g for 10 min (for purified myosin). After the washing procedure, either the SNO-RAC (for myotubes) or the biotin-switch assay (for EDL muscles, skinned fibres and myosin) was carried out as described below.
To detect myosin-SNO in C2C12 myotubes, cells were lysed in ice using 400 μl of RIPA buffer (50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1 % Nonidet P40, 0.5 % sodium deoxycholate and 0.1 % SDS) supplemented with 0.5 mM PMSF and a cocktail of protease inhibitors followed by centrifugation at 12 000 g for 10 min at 4
• C. The supernatant was allowed to react with 1.6 ml of blocking buffer (buffer B plus 2.5 % SDS and 20 mM MMTS) for 20 min at 50
• C with frequent vortex-mixing followed by 6 ml of pre-chilled acetone and precipitation for 20 min at −20
• C. Some samples were photolysed in 1.6 ml of buffer B plus 2.5 % SDS for 10 min using a mercury vapour lamp as described in [22] and allowed to react with 20 mM MMTS, followed by acetone precipitation as above. After centrifugation at 2000 g for 10 min at 4
• C, the pellet was washed with acetone and resuspended in 0.5 ml of buffer B plus 1 % SDS, 20 mM ascorbate and 40 μl of thiopropyl-Sepharose 6B and allowed to react for 2 h at room temperature (25 • C) under rotation to capture the SNO proteins by SNO-RAC [24] . All of the steps were carried out in the absence of light. The resin was washed five times with 1 ml of buffer B plus 1 % SDS and twice with buffer B diluted 1:10 with 1 % SDS (buffer B/10 SDS) followed by elution with buffer B/10 SDS plus 2 % 2-mercaptoethanol for 1 h at room temperature. The proteins were separated by SDS/PAGE (4-15 % gels) and transferred on to a nitrocellulose membrane or stained with Coomassie Blue R. Myosin input or the pull-down was immunoblotted using the monoclonal antibody for MHC (1:2000) followed by secondary anti-mouse IgG (1:10 000), and MHC was detected using ECL ® (enhanced chemiluminescence) Plus (GE Healthcare).
For the myofibrillar proteins from EDL muscle (see above) or skinned fibres, 2.5 % SDS and 0.1 M MMTS were added to the supernatant and then proteins were precipitated with acetone after 1 h. In both cases, the precipitated proteins were solubilized in buffer B plus 1 % SDS, and SNO sites were switched to biotin tags by incubating with ascorbate and biotin-HPDP for 2 h at room temperature. For purified myosin, solubilization was in blocking buffer containing 2.5 % SDS and 40 mM MMTS. In these cases, pull-down was not performed and the protein-SNO was detected in the blot by total thiobiotinylation using streptavidin-horseradish peroxidase (1:8000 dilution) followed by the ECL ® reaction as described above and comparison with the total protein in the Coomassie Blue R staining using Image Quant 5.2 (Molecular Dynamics).
Myosin and actomyosin ATPase activity
After treating myosin with GSNO followed by two to five washes and resuspension as described above, 0.1 ml (∼ 0.1 mg of protein) was used to measure myosin ATPase activity in a final volume of 1 ml in the presence of 3 mM ATP at 30
• C. This procedure ensured a dilution of the original GSNO by a factor of ∼ 13 000, after two washes. The samples were pre-incubated at 30
• C for 2 min at a final concentration of 0.05-0.2 mg/ml myosin either in Mg 2+ buffer (for Mg 2+ -ATPase) or in 0.6 M KCl, 5 mM EDTA and 50 mM imidazole, pH 7, for K + -EDTA-ATPase, or in 50 mM KCl, 50 mM imidazole, pH 7, 0.2 mM EDTA and 5 mM CaCl 2 for Ca 2+ -ATPase activity. Hydrolysis was started by adding 3 mM ATP and interrupted by activated charcoal suspended in 0.1 M perchloric acid followed by centrifugation at 3000 g for 25 min to remove the charcoal. The supernatants were analysed colorimetrically to determine P i release. The time course of hydrolysis was linear in all cases. To investigate the effects of NO
• on Mg 2+ -ATPase activity, myosin was treated with DEANO (50 μM-2 mM) for 30 min in Mg 2+ buffer, followed by dilution (1:10) in Mg 2+ buffer containing 3 mM ATP. A control experiment showed that the half-time for decay of 1 mM DEANO at pH 7 was 4 min, so that 30 min was adequate for conversion of NO
• into the S-nitrosylating species NO 2 • and N 2 O 3 . Actin-activated myosin ATPase activity was measured after myosin S-nitrosylation followed by two washes and resuspension. Hydrolysis was started by adding 50 μl of modified myosin (final concentration 0.1-0.2 mg/ml) to ATPase medium in the presence of actin (60 mM KCl, 50 mM imidazole, pH 7, 5 mM MgCl 2 , 1 mM EGTA, 3 mM ATP and 0-0.5 mg/ml actin). After 10 min, the reaction was interrupted as described above but with 1 M perchloric acid, and P i was measured as before. Actin-activation of myosin was calculated by subtracting the specific activity of myosin from the total ATPase activity in the presence of actin. Kinetic parameters (K m and V max ) were determined by fitting the data with a rectangular hyperbola.
Detection of myosin thiol groups
The number of free thiol groups in native and unfolded myosin was measured in the same buffers as those used for S-nitrosylation (see above), but without GSNO. Myosin (0.25 mg/ml) was incubated with 500 μM DTNB for 2 h at pH 7 and 25-30
• C, and the time course of TNB − (2-nitro-5-thiobenzoate) release was analysed at 412 nm (ε 412 = 13600 M −1 · cm −1 ) [25] . The free thiol groups of myosin-SNO could not be analysed with DTNB, since TNB − decomposes RSNO, overestimating the real number of free thiols [26] .
Alkylation of myosin
In the experiments of Figure 5 (D)-5(E), to block the most reactive thiol groups, myosin (5 mg/ml) was treated with NEM (1 mM) for 30 min at 25
• C in Mg 2+ buffer, and the reaction was stopped with 10 mM DTT, followed by extensive dialysis to remove excess NEM and DTT [10] . The remaining number of accessible thiols was determined using DTNB in the presence (native) and absence of GdmCl (unfolded myosin). During NEM treatment, the ATPase activity in the presence of Mg 2+ buffer showed the expected activation at short times followed by inhibition at longer times, and, in the presence of K + EDTA buffer, only inhibition was observed. This pattern is characteristic of alkylation of the more reactive thiols in each head, including Cys 707 and Cys 697 [10] . In Figure 5 (D), the GSNO concentration-dependence of Snitrosylation in non-alkylated and alkylated myosin was fitted using a rectangular hyperbola (eqn 1):
where SNOmyo and SNOmyo o represent S-nitrosylation determined by Saville's method in myosin treated or not with GSNO, SNOmyo max is the maximum myosin-SNO formation; and K 0.5 is the GSNO concentration for half-maximum myosin-SNO formation.
Statistical analyses
The experimental results are presented as means + − S.E.M. For comparison between two groups, Student's t test was used, paired or unpaired as required. For multiple comparisons, a one-way ANOVA followed by the Tukey test or a two-way ANOVA was used, as indicated. Analyses were carried out using GraphPad Prism 4 software and P < 0.05 was considered to represent a significant difference.
RESULTS

High-intensity exercise increases protein S-nitrosylation in EDL muscle
As an initial investigation, we subjected rats to a session of intense exercise in order to determine whether these conditions would promote protein S-nitrosylation within fast-twitch EDL muscle. We first measured NO 2 − and RSNO in a fraction enriched with myofibrillar proteins. Exercise resulted in an approx. 2-fold increase in NO 2 − from levels found at rest (1.07 + − 0.20 nmol of NO 2 − /mg of protein compared with 0.52 + − 0.06 nmol of NO 2 − /mg of protein respectively; P < 0.05, n = 9; Figure 1A ), suggestive of exercise-induced NO
• production. SNOs, detected as Hg 2+ -displaceable NO 2 − , were barely detectable in resting muscle, but were significantly increased in muscle from exercised rats (0.05 + − 0.03 nmol of RSNO/mg of protein compared with 0.30 + − 0.16 nmol of RSNO/mg of protein respectively; P < 0.05, n = 8; Figure 1B ). Collectively, these data point to an increase in NO production and concomitant S-nitrosylation in fast-twitch skeletal muscle as a result of intense exercise. In a second experiment, we utilized the biotin-switch technique to assess the speciation of protein SNOs. As above, rats were subjected to a session of intense exercise or not, and the EDL muscles were processed to obtain a fraction enriched in myofibrillar proteins. Snitrosylation of a ∼ 200 kDa band, prominent among myofibrillar proteins, increased in high-intensity exercise ( Figures 1C and 1D) .
Myosin is the major target of S-nitrosylation in myotubes and in skinned muscle fibres
The majority of proteins of skeletal muscle are those associated with the thick filaments (e.g. myosin) and thin filaments (e.g. actin, tropomyosin and troponin complex). Among these proteins, we speculated that MHC was the identifiable target of exerciseinduced S-nitrosylation ( Figure 1D ). To positively identify myosin as a target of S-nitrosylation, differentiated C2C12 myotubes were treated with CysNO and were subsequently assayed by SNO-RAC, a newly-described assay for S-nitrosylated proteins that, compared with the biotin-switch assay, detects more sensitively high-molecular-mass SNO-proteins [24] . The reaction of myotubes with CysNO resulted in S-nitrosylation of a ∼ 200 kDa protein ( Figure 2A , lane 2; arrow indicates the MHC that was prominent among total cellular proteins), and it disappeared when CysNO was omitted or when pre-photolysis was applied. Western blotting identified S-nitrosylated MHC (myosin-SNO) in pull-downs from CysNO-treated C2C12 cells ( Figure 2B) ; the specificity of the assay was confirmed by both ascorbate-dependence and UV pre-photolysis (which results in homolysis of the S-NO bond [22] ). A time course revealed that myosin-SNO persisted for at least 60 min following addition of CysNO, suggesting that myosin-SNO may be more stably Snitrosylated than the majority of intracellular protein-SNOs [24] . We also investigated S-nitrosylation of skinned muscle fibres, which contain intact myofibrillar proteins, but lack many cytosolic constituents. These permeabilized fibres should be accessible to GSNO, which, unlike CysNO, does not readily cross the cell membrane and did not promote myosin-SNO formation in intact C2C12 cells (results not shown). On the basis of the well-known distribution of proteins within these fibres [27] , MHC and actin were identified as the primary targets of this physiologically relevant low-mass SNO ( Figure 2D ). An examination of total thiol biotinylation revealed that free cysteine residues in many other proteins were not reactive towards GSNO ( Figure 1C) . Collectively, these data demonstrate that MHC is a major cellular target of S-nitrosylation. There are two recent reports of S-nitrosylation on cardiac myosin light chains in vitro [28, 29] , and, in another study, the cardiac MHC was S-nitrosylated in intact hearts following ischaemic perfusion [30] . There are no reports, however, that correlate skeletal muscle myosin S-nitrosylation with a change in function.
S-nitrosylation regulates the
Myosin exhibits pronounced differences in activity under various ionic conditions, presumably reflecting conformational changes associated with the binding of K + , Mg 2+ or Ca 2+ to the motor domain [31] as well as the stability of the cation-ATP complex at the catalytic site. Using these three classical ionic conditions, we first explored the effects of GSNO (15 min of Non-reducing SDS/PAGE (10 % gels) of skinned muscle fibre proteins after the biotin-switch technique as described in the Experimental section, either stained with Coomassie Blue or after Western blotting biotinylated proteins following chemiluminescence development for 5 min (PC) or 15 min (Negative control and 0-1 mM GSNO). Protein identification was based on molecular masses of SigmaMarker TM Wide Range (6.5-205 kDa) correlated with muscle proteins in skinned fibres [27] and with the mobility of purified myosin, S1, TnI (troponin I) and TnC (troponin C). MLC 2, myosin light chain 2; Negative control when proteins were reduced by DTT treatment followed by MMTS and the biotin-switch technique; PC, positive control for biotinylation when MMTS was replaced with DTT followed by the biotin-switch protocol; TM, tropomyosin; TnT, troponin T.
incubation followed by a single wash) on myosin ATPase activity in vitro (Table 1) . Interestingly, the Mg 2+ -ATPase activity of myosin was inhibited by up to ∼ 25 % upon treatment with GSNO (Table 1 and Figure 3A , open circles), whereas neither the Ca 2+ -nor the K + -EDTA-ATPase activity was altered (Table  1) . Myosin was also dose-dependently S-nitrosylated by GSNO under identical conditions ( Figure 3B and Supplementary Figure  S1A at http://www.BiochemJ.org/bj/424/bj4240221add.htm), consistent with the idea that modifications of cysteine thiol(s) on myosin were responsible for its inhibition. Quantification of myosin S-nitrosylation using the Saville assay revealed that maximal inhibition of Mg 2+ -ATPase activity correlated with S-nitrosylation of four to six cysteine thiols per myosin ( Figure  3D ).
We also found that a longer incubation with GSNO (60 min) greatly enhanced both its inhibition of Mg 2+ -ATPase activity ( Figure 3A , inset) and myosin S-nitrosylation ( Figure 3C and Supplementary Figure S1B) . In fact, under these conditions, significant inhibition was observed with as little as 5 μM GSNO, which approaches physiological levels of this endogenous SNO. However, the nitric oxide donor DEANO neither inhibited nor markedly S-nitrosylated myosin ( Figures 3A and 3B and Supplementary Figure S1A ). These data suggest that myosin regulatory thiol(s) react relatively slowly with GSNO and that transnitrosylation between GSNO and myosin, but not the reaction of NO
• (a possible product of GSNO decomposition), was responsible for myosin S-nitrosylation in vitro. A similar result was reported for the cardiac ryanodine receptor RyR2, which, unlike the skeletal muscle protein RyR1, is also S-nitrosylated by GSNO, but not by NO
• [32] . GSNO appears to be a potential physiologically relevant mediator of myosin S-nitrosylation, although these data cannot rule out the possibility that oxidative reactions between NO
• and myosin, which are apparently disfavoured even under aerobic conditions in vitro, also govern endogenous myosin S-nitrosylation ( Figures 1C  and 1D ).
Actin-myosin affinity is not affected by GSNO
Myosin's ability to bind to actin during the cross-bridge cycle, increasing the ATPase activity, is fundamental to its chemomechanical role in muscle. To determine whether the maximal ATPase activation or actin-myosin affinity is affected by GSNO, myosin was allowed to react with 0.1-4 mM GSNO in Mg 2+ buffer for 15 min at 30
• C followed by two washes. The actin-activation of modified myosin was induced by adding it to Mg 2+ buffer containing ATP and various concentrations of actin. Figure 4 (A) shows an example of the actin-activation of myosin prepared as described in Figure 3(A) (two washes,  open circles) . On average, the maximal activity decreased in a concentration-dependent manner, approaching a plateau value (≈ 20 % inhibition) after treatment with 2 mM GSNO (Figure 4B) . There was no effect on myosin's affinity for actin ( Figure 4A) , and thus the effect of GSNO on the actomyosin ATPase can be attributed to its effect on the catalytic cycle of myosin alone.
Stability of myosin-SNO groups and inhibition of the ATPase
A number of different proteins that can be S-nitrosylated in vitro have been shown to lose the SNO groups subsequently, at different rates and by different mechanisms, including release of NO
• to the medium and transfer of the nitroso group to other proteins. Although it was not our objective to explore possible routes of myosin-SNO decomposition, we did compare the stability of the S-nitrosylated cysteine residues with the inhibition of ATPase activity, using for convenience a relatively short incubation time (15 min) and a wide range of GSNO concentrations. As described below, these same experiments were useful for eliminating the possibility of overestimating SNO groups because of contaminant GSNO trapped in the myosin pellet. Figure 5 (A) shows that the Mg 2+ -ATPase activity is inhibited by GSNO to the same extent after simple dilution (1:10) and after one and two washes (P>0.05). During the washing procedure, the GSNO dilution in the medium is significantly increased from 10-fold (no washing), to 440-fold (one wash) and approx. 13 000-fold (two washes). Thus it is unlikely that contaminant GSNO is responsible for inhibition of the ATPase. However, after five washes, the inhibitory effect of GSNO is lost completely ( Figure 5A ).
To understand why the inhibitory effect is lost after extensive washing, we quantified myosin-SNO groups after two and five washes, and found a marked reduction after five washes ( Figure  5B , P < 0.05). Thus with 1 mM GSNO, for example, 5.0 + − 0.3 mol of SNO/mol of myosin (two washes) is decreased to 1.0 + − 0.1 mol/mol after five washes, and there is a corresponding loss of the inhibitory effect on activity ( Figure 5A ). For both sets of data, the number of SNO groups remaining after washing is significantly different from the untreated sample (i.e. 0 mM GSNO, Figure 5B , P < 0.05). This observation suggests that the loss of myosin-SNO groups after washing is related primarily to the lability of some of these groups, and not merely to the removal of contaminant GSNO. We infer from the data in Figures 5(A) and 5(B) that S-nitrosylation of myosin by GSNO produces two populations of SNO groups: a more labile one (about four SNO groups per myosin), which includes some groups that inhibit the ATPase; and a population that does not affect the activity, but is more stable. These results reinforce and extend the conclusion drawn from Figure 3 (D): inhibition arises from S-nitrosylation of no more than four to six labile cysteine residues, and possibly fewer.
The more stable SNO groups are located in less accessible regions
The stability of protein-SNO groups is associated with the environment of the SNO group in the molecule. The nature and proximity of neighbouring amino acid residues can increase or decrease its rate of decomposition [33] . To characterize further the more stable myosin-SNO groups formed after reaction with GSNO, NEM was used to block the more reactive thiols and Snitrosylation was measured after reaction with GSNO followed by five washes, which eliminates the more labile SNO groups ( Figures 5C and 5D ).
As can be seen in Figure 5 (D), the treatment with 1 mM NEM significantly reduced the stable myosin-SNO groups formed at high GSNO concentrations (from 4.8 + − 0.1 to 2.5 + − 0.5 mol/mol in 8 mM GSNO for native and NEM-myosin respectively; P < 0.05), but NEM had no effect at low GSNO concentrations (1.7 + − 0.2 and 2.3 + − 1.0 mol/mol in 1 mM GSNO for native and NEM-myosin respectively). These data show that between two and three cysteine residues (filled squares in Figure 5D ) that contribute to the more stable group of SNO were not alkylated, suggesting that these cysteine residues are reactive to GSNO, but not to NEM. The two cysteine residues lost to S-nitrosylation by their reaction with NEM (open squares at 8 mM GSNO in Figure  5D ) do not affect the ATPase activity, since the alkylated myosin was washed thoroughly beforehand. Since S-nitrosylation with GSNO followed by two washes produces four to six myosin-SNO groups ( Figure 5B), and two to three of them belong to the stable group, one or both of the other two labile SNO groups must promote the inhibitory effect of S-nitrosylation.
To relate the stable SNO groups with the reactivity and availability of thiols in myosin, DTNB was used after the alkylation step to measure the number of free thiol groups. The protein was alkylated in the folded state with NEM, and free thiols were determined in the folded (without GdmCl) and unfolded (with GdmCl) protein ( Figures 5C and 5E ). Under both conditions, NEM-myosin had a decreased number of free thiol groups relative to non-alkylated myosin ( Figure 5E ). The difference in free thiol content of native myosin and NEM-myosin was 10 + − 2 mol of thiol/mol of myosin when measured in the folded state and 11 + − 2 mol of thiol/mol of myosin when measured in the unfolded state ( Figure 5E ; P > 0.05). This result shows that alkylation reaches the more accessible thiols in myosin, since the alkylation step in both cases was carried out in the native state. Thus it seems likely that, among these ten or eleven alkylated cysteine residues, located in regions more exposed to the solution, one or two can form stable SNO groups and the eight to ten remaining thiols can form more labile SNO groups. We infer that some of these latter more exposed residues are responsible for the inhibition of ATPase activity by S-nitrosylation.
DISCUSSION
The principal findings of the present study are that myosin can be extensively S-nitrosylated both in vivo and in vitro and the physiological ATPase activity can be affected by a few labile SNO groups that inhibit Mg 2+ -ATP hydrolysis, but do not alter the affinity of myosin for actin. Evidence is presented to show that the mechanism is one of transnitrosylation rather than a direct effect of NO
• .
Figure 5 Stability of myosin SNO groups with washing, alkylation and GdmCl
(A) Loss of inhibitory effect on Mg 2+ -ATPase activity by extensive washing. GSNO treatment (15 min in Mg 2+ buffer) was followed by 1:10 dilution without washing (᭹; n = 3) and one ( ; n = 6), two (᭺; n = 3) or five (ᮀ; n = 3) washes. Results are means + − S.E.M. Only the curve with five washes is significantly different from the others (P < 0.05, two-way ANOVA test). (B) Myosin was allowed to react with GSNO as in (A), followed by two or five washes. Myosin-SNO content was determined by Saville's method. *P < 0.05 compared with 0 mM GSNO; **P < 0.05 compared with five washes (one-way ANOVA). (C) Scheme showing the alkylation of the most reactive thiol groups in myosin by NEM (see the Experimental section). Alkylated () and non-alkylated (ᮀ) myosins were purified by extensive dialysis and, in (D), treated with GSNO (0.25-8 mM) for 15 min at 30 • C followed by five washes, and myosin-SNO content was measured by Saville's method. Results are means + − S.E.M.; n = 3. *P < 0.05 compared with non-alkylated myosin (paired Student's t test). A rectangular hyperbola was used to fit the results (eqn 1). There is a significant difference in the maximum number of myosin-SNO bonds in alkylated (6.5 + − 0.7 mol of SNO/mol of myosin) compared with non-alkylated myosin (2.4 + − 0.1 mol of SNO/mol of myosin; P < 0.05, paired Student's t test). In (E), alkylated and non-alkylated myosins were treated with DTNB (0.5 mM) for 2 h in the absence (native, folded protein) or presence of 2 M GdmCl (unfolded protein), and free thiol groups were measured by absorption at 412 nm. Results are means + − S.E.M.; n = 3. *P < 0.05 (paired Student's t-test) compared with control or control + GdmCl.
We did not undertake a detailed study of S-nitrosylation in vivo, but there was a clear increase in total RSNO and protein-SNO levels of a band corresponding to the molecular mass of MHC in rat fast-twitch muscle following intense exercise (Figure 1 ). An increase in protein-SNO levels with exercise is consistent with previous reports showing that stimulation increases intracellular NO
• [4, 34] as well as NO
• release [35] from skeletal muscle by activation of the Ca 2+ -dependent nitric oxide synthases. Similar results have been obtained in experiments with cardiac myocytes [36] .
Even though many muscle proteins have their function changed by S-nitrosylation in vitro, it has never been demonstrated that S-nitrosylation occurs in myofibrils. In the present study, we show that in both C2C12 myotubes, a well-known differentiated cell type that expresses myofibrillar proteins [18] , and skinned fibres, where the sarcolemma is disrupted by EGTA and there is extensive loss of cytosolic proteins [37] , a pharmacological challenge by CysNO or GSNO leads to S-nitrosylation primarily of myosin and actin. The data show that many other proteins are susceptible to thiol modification, but are not S-nitrosylated (Figure 2 ). The evident S-nitrosylation of actin in skinned muscle fibres is consistent with reports showing actin-SNO in non-muscle cells [38] and in homogenates of heart muscle [30] , suggesting that this protein may be a ubiquitous site for S-nitrosylation of the cytoskeleton. However, other proteins such as tropomyosin and troponin (C+T+I), which have cysteine residues, are not visibly affected up to 0.5 mM GSNO (Fig. 2D) . Together with the observation that myosin can be readily S-nitrosylated in skinned fibres and in C2C12 myotubes, these experiments raise the possibility of a (patho)physiological role for myosin Snitrosylation in vivo.
One way in which this could occur would be via a direct reaction of NO
• or its auto-oxidation products with myosin thiols. This route appears to be unlikely, since myosin-SNO did not form when NO • was provided by DEANO decomposition (Figures 3A and 3B ). Our experiments with GSNO and CysNO, however, show that myosin is susceptible to transnitrosylation. Considering that muscle fibres contain an ample supply of glutathione, an important physiological anti-oxidant and a GSNO precursor, an increase in NO
• produced by activation of nNOS (neuronal nitric oxide synthase) or eNOS (endothelial nitric oxide synthase) in vivo, could lead to an increase in GSNO followed by transnitrosylation of susceptible myosin thiols. Under pathophysiological conditions, such as endotoxaemia or obesity, an additional source of NO
• would be provided by induction of iNOS (inducible nitric oxide synthase) [39] . The concentration of GSNO in muscle is not known, but estimates of intracellular GSNO concentration in other cells vary widely, from ∼ 2 μM (in cerebellum [40] ) to 50 μM (in aorta [41] ) and even 200 μM (in mitochondria [42] ). However, GSNO is generally thought to be compartmentalized, meaning that higher values may be encountered locally, and homogenization will certainly disrupt the normal distribution [43, 44] . A clue to its physiological concentration in the cytosol is provided by the K m of GSNO reductase (4.8 μM in humans, 20 μM in mice), which is important in GSNO metabolism [45, 46] .
A legitimate concern in evaluating this proposal is the question of whether NO
• can ever reach significant concentrations in muscle fibres, given the presence of oxymyoglobin, a putative NO
• scavenger. Recent experiments with intracellular fluorescent probes for NO
• show clearly that it increases substantially in stimulated skeletal and cardiac cells [4, 34, 36] , and so does protein-SNO [30, 39] . Thus physiological levels of oxymyoglobin do not eliminate these responses, and in fact the idea that myoglobin will always serve as a sink for NO
• has been questioned [47] .
A second concern that is relevant to the possible significance of myosin S-nitrosylation in vivo is that of O 2 concentration. In some proteins, such as the skeletal muscle ryanodine receptor RyR1 [33] , regulation of a critical thiol by S-nitrosylation occurs only at low O 2 concentrations characteristic of the in vivo situation, whereas in other proteins (e.g. the cardiac receptor RyR2 [32] ), the O 2 tension has no effect on SNO formation. All of our experiments in vitro were carried out in solutions equilibrated with atmospheric O 2 , well above the level expected in living muscle. Thus it will be important to examine the dependence of myosin S-nitrosylation on O 2 tension before concluding that it has a role in vivo.
The thiol groups of protein cysteine residues have different reactivities depending on thiol pK a and three-dimensional structure, which can increase or decrease the tendency for Snitrosylation [33] and denitrosylation [48] . One of our goals was to determine whether S-nitrosylation reveals different classes of thiols in myosin, and we started by evaluating its effects on myosin ATPase activities. Myosin contains 42 cysteine residues, and different populations of thiol groups have been described, based on their reactivity to thiol-group-specific reagents and the resulting changes in ATPase activity [1, 10, 31] . In our experiments, maximal inhibition of the Mg 2+ -ATPase in 15 min was attained after S-nitrosylation of four to six cysteine residues ( Figure 3D ), apparently with no contribution from the other SNO groups formed by transnitrosylation at higher GSNO concentrations. When the same S-nitrosylation was carried out in Ca 2+ or K + -EDTA buffer, there was no effect whatsoever on myosin activity in these buffers (Table 1 and data not shown). The so-called 'essential' thiols Cys 707 (SH1) and Cys 697 (SH2) are among the first to react with classical thiol-group-specific reagents, and provide the basis for these reagents' inhibiting the K + -EDTA ATPase activity as well as for first activating and then inhibiting the Ca 2+ and Mg 2+ -ATPase activities [10] . The fact that this profile does not appear when myosin is S-nitrosylated may be an indication that these two cysteine residues are not susceptible to attack by GSNO.
Our experiments with actomyosin provide additional evidence that S-nitrosylation may not affect SH1 or SH2. Alkylation of myosin with NEM enhances the affinity between actin and myosin, even in the presence of Mg 2+ -ATP, and reduces the maximal actin activation [49] . Once again, the profile does not match: after S-nitrosylation, maximum actin activation is decreased, but actomyosin affinity is maintained (Figures 4A  and 4B ). We infer that the time-and concentration-dependent inhibition of the Mg 2+ -ATPase may be a consequence of S-nitrosylation of some cysteine residue(s) other than SH1 or SH2. It is also possible that SH1 and SH2 are S-nitrosylated without functional impairment. In this regard, it is of interest that Sakamoto et al. [50] have described a thiol-group-specific reagent that reacts with a single residue in each myosin head, without modifying either SH1 or SH2. The effect on ATPase activities is very different from the pattern observed when SH1 or SH2 is modified. Ultimately, the fate of SH1 and SH2 during S-nitrosylation will have to be settled using mass spectrometry. We have tried repeatedly to identify S-nitrosylated cysteine residues of myosin peptides using this method, but so far have been unable to achieve satisfactory coverage of the MHC.
Our second approach to assignment of myosin-SNO to different thiol populations was based on their different stabilities to washing with deionized water in the absence of chelating agents. This simple procedure leads to loss of a more labile population of SNO groups, some of which affect the Mg 2+ -ATPase activity. First, it is clear that some fraction of the four to six SNO groups that survive after two washes promotes the inhibitory effect on the Mg 2+ -ATPase activity ( Figures 5A and 5B ). However, after five washes, the inhibitory effect is abolished completely, and the myosin S-nitrosylation is drastically reduced to 2-3 mol/mol. This suggests that there are two groups of SNOs in myosin: one more labile, which affects ATPase, and the other more stable, with no effect. The thiols that are transiently S-nitrosylated have the potential to modulate the demand for ATP in situations where the production of nitric oxide increases during muscle contraction.
As an additional strategy to investigate the relationship between different thiol populations and the SNO groups we have found in myosin, we concentrated on the more stable S-nitrosylation. In these experiments, we first alkylated the more reactive and accessible thiol groups of the native protein with NEM. In this condition, in agreement with Watterson et al. [51] , ten cysteine residues are blocked ( Figure 5E ). After this procedure, the protein was exposed to GSNO, followed by five washes, to study the more stable SNO groups. The SNO content of myosin alkylated and then S-nitrosylated in this way was decreased only in high GSNO concentrations, from ∼ 5 to ∼ 3 mol/mol for native and alkylated myosin respectively. This means that, at most, only 20 % (two out of ten) of the total number of thiols accessible to alkylation can form stable SNO groups, whereas the other alkylated cysteine residues undergo labile S-nitrosylation. Since unfolding the protein with GdmCl before the alkylation step does not increase the number of cysteine residues blocked by NEM, we infer that all of the alkylated thiols are located on residues that are more accessible to the solvent in the native protein, including those (six out of ten) that form the more labile SNO groups; their geometry might well account for the higher rate of RSNO decomposition [33] . Conversely, as with other proteins [52] , stable SNO bonds may be associated with limited accessibility of the solvent to the interior of the protein. Recently, Paige et al. [48] presented evidence from a range of different proteins that stable SNO groups may form when S-nitrosylation induces a conformational change that blocks access of glutathione to the reactive thiol, even one on the surface. Our data with myosin suggest only that the SNO sites belong to two classes of thiols: those in more exposed regions, which bind transiently to nitroso groups and affect Mg 2+ -ATPase activity, and those in more buried regions on myosin, which form stable S-nitrosylation sites, but do not inhibit ATPase activity.
Formation of 3-nitrotyrosine and protein disulfide bonds can also occur with GSNO, and would not be detected by the Saville assay, where specificity is conferred by the reaction of Hg(II) with sulfur in the RSNO [53] . If these other bonds are formed, it seems unlikely that they are responsible for inhibition of the ATPase in our experiments, since they are inherently more stable than SNO modifications and are not easily lost simply by washing the protein [11] .
The force production in skeletal muscle fibres is the result of Ca 2+ release from the sarcoplasmic reticulum, activation of the thin filament by Ca 2+ and power stroke production by myosin on the thin filament. Significant decreases in maximal force and unloaded shortening velocity have been obtained using SNO donors either in skinned fibres [6, 54] or in intact fibres [7, 30] . Inhibition of contraction by SNOs in intact fibres appears to involve Ca 2+ release from the sarcoplasmic reticulum [7, 30, 55] . In skinned fibres, however, this component can easily be eliminated, leaving only cross-bridges and Ca 2+ regulation of the thin filament as potential targets. A somewhat larger effect on Ca 2+ sensitivity suggests additional sites of action on the interacting filaments [6, 8] . Inhibition of the Mg 2+ -ATPase activity of myosin and actomyosin by GSNO provides a plausible explanation for these functional effects of SNO donors in muscle fibres.
During skeletal muscle activation, Ca 2+ released by the sarcoplasmic reticulum promotes both muscle contraction and activation of nitric oxide synthase. This transient increase in NO
• production could form reversible SNO bonds in proteins only during muscle contraction. Different authors have proposed that a reversible S-nitrosylation reaction would serve to protect cysteine residues from irreversible oxidation during ischaemia [30, 33, 44] . In skeletal muscle, myosin is present in such large amounts that its labile SNO groups could act as a buffer against a transient increase of low-molecular-mass RSNO in muscle fibres during nitrosative stress or contractile activity. It is interesting that only the Mg 2+ -ATPase activity is inhibited by GSNO. Further study will be required to establish whether S-nitrosylation of a specific residue is responsible for this effect. 
